Chemoselection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma with cartilage invasion
Worden, Francis P.; Moyer, Jeffrey S.; Lee, Julia S.; Taylor, Jeremy M. G.; Urba, Susan G.; Eisbruch, Avraham; Teknos, Theodoros N.; Chepeha, Douglas B.; Prince, Mark E. P.; Hogikyan, Norman D.; Lassig, Amy Anne D.; Emerick, Kevin; Mukherji, Suresh K.; Hadjiski, Lubomir; Tsien, Christina I.; Miller, Tamara H.; Wallace, Nancy E.; Mason, Heidi L.; Bradford, Carol R.; Wolf, Gregory T.
2009-08
Citation
Worden, Francis P.; Moyer, Jeffrey; Lee, Julia S.; Taylor, Jeremy M. G.; Urba, Susan G.; Eisbruch, Avraham; Teknos, Theodoros N.; Chepeha, Douglas B.; Prince, Mark E.; Hogikyan, Norman; Lassig, Amy Anne D.; Emerick, Kevin; Mukherji, Suresh; Hadjiski, Lubomir; Tsien, Christina I.; Miller, Tamara H.; Wallace, Nancy E.; Mason, Heidi L.; Bradford, Carol R.; Wolf, Gregory T. (2009). "Chemoselection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma with cartilage invasion Presented at the 43rd Annual ASCO Meeting, Chicago, Illinois, U.S.A., June 2, 2007 and the 7th International Conference on Head and Neck Cancer, San Francisco, California, U.S.A., June 20, 2008. ." The Laryngoscope 119(8): 1510-1517. <http://hdl.handle.net/2027.42/63548>
Abstract
Objectives/Hypothesis: High rates of overall survival (OS) and laryngeal preservation were achieved in two sequential phase II clinical trials in patients with stage III/IV laryngeal squamous cell carcinoma (SCC). Patients were treated with chemoradiation after a >50% primary tumor response to one cycle of neoadjuvant chemotherapy (IC). We analyzed outcomes for T4 patients with cartilage invasion from both studies. Study Design: Retrospective. Methods: Records from 36 patients with T4 SCC of the larynx with cartilage invasion alone (n = 16) or cartilage invasion and extralaryngeal spread (n = 20) were retrospectively reviewed. All were treated with one cycle of cisplatin (100 mg/m 2 ) [or carboplatin (AUC 6)] and 5-fluorouracil (1,000 mg/m 2 /d for 5 days) (P+5FU). Those achieving >50% response at the primary tumor received chemoradiation (70 Gy; 35 fractions with concurrent cisplatin-100 mg/m 2 [carboplatin (AUC 6)] every 21 days for 3 cycles), followed by adjuvant P+5FU for complete histologic responders (CHR). Patients with <50% response after IC underwent total laryngectomy and postoperative radiation. Results: Twenty-nine of 36 patients (81%) had >50% response following IC. Of these, 27 received definitive chemoradiation, 23 (85%) obtained CHR, with 58% laryngeal preservation rate. The 3-year OS was 78%, and the disease-specific survival was 80% (median follow-up 69 months). Following chemoradiation, 8/11 (73%) patients with an intact larynx had >75% understandable speech, 6/36 (17%) were g-tube dependent and 6/36 (17%) were tracheostomy dependent. Conclusions: Our results suggest that chemo-selection is a feasible organ preservation alternative to total laryngectomy for patients with T4 laryngeal SCC with cartilage invasion. Laryngoscope, 2009Publisher
Wiley Subscription Services, Inc., A Wiley Company
ISSN
0023-852X 1531-4995
Other DOIs
PMID
19504552
Types
Article
Metadata
Show full item recordRemediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.